The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Patient outcomes after therapy with 177Lu-PSMA-617 (LuPSMA) for metastatic castrate-resistant prostate cancer (mCRPC): A tertiary center experience.
 
Meryam Losee
No Relationships to Disclose
 
Nuno Vaz
No Relationships to Disclose
 
Jolivette Ritzer
No Relationships to Disclose
 
Andrew Wolanski
Stock and Other Ownership Interests - Novartis
 
Sudhir Bhimaniya
No Relationships to Disclose
 
Atish Dipankar Choudhury
Employment - LeMaitre Vascular (I)
Honoraria - Aptitude Health; Bayer; Cancer Network; Clinical Care Options; Color Genomics; Great Debates and Updates; Journal of Clinical Pathways/Oncology Learning Network; Lantheus Medical Imaging; OncLive; Pfizer; Physicans' Education Resource; Springer; Targeted Oncology; Wiley
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bayer; Blackstone; Blue Earth Diagnostics; Janssen Oncology; Lilly; Pfizer; Sanofi/Aventis; Tolmar
Research Funding - Bayer; Janssen (Inst); Pfizer (Inst)
 
Hyewon Hyun
No Relationships to Disclose
 
Emma Kelly
No Relationships to Disclose
 
Kerry L. Kilbridge
Research Funding - American Cancer Society/Pfizer
 
Alicia K. Morgans
Honoraria - Advanced Accelerator Applications; Astellas Pharma; Astellas Scientific and Medical Affairs Inc; AstraZeneca; Bayer; Clovis Oncology; Exelixis; Genentech; Janssen; Janssen; Janssen Oncology; Merck; Myovant Sciences; Pfizer; Sanofi; Telix Pharmaceuticals
Consulting or Advisory Role - Advanced Accelerator Applications; Astellas Pharma; AstraZeneca; Bayer; Blue Earth Diagnostics; Exelixis; Janssen; Lantheus Medical Imaging; Merck; Myovant Sciences; Myovant Sciences; Myriad Genetics; Novartis; Sanofi
Research Funding - Astellas Scientific and Medical Affairs Inc; AstraZeneca; Bayer; Dendreon; Genentech; Myovant Sciences; Sanofi; Seattle Genetics/Astellas
Travel, Accommodations, Expenses - Sanofi; Telix Pharmaceuticals
 
Mark Pomerantz
Honoraria - Bayer
 
Matthew Robertson
No Relationships to Disclose
 
Christopher Sakellis
No Relationships to Disclose
 
Hina Shah
No Relationships to Disclose
 
Rajitha Sunkara
No Relationships to Disclose
 
Mary-Ellen Taplin
Honoraria - Abbvie; Arcus Biosciences; Arvinas; AstraZeneca; Blue Earth Diagnostics; Clovis Oncology; Constellation Pharmaceuticals; Epizyme; Hengrui Therapeutics; Janssen-Ortho; Pfizer; Propella Therapeutics; Research to Practice; Roivant; Targeted Oncology; UpToDate
Consulting or Advisory Role - Arcus Ventures (I); AstraZeneca; Bayer; Best Doctors, Inc; Clovis Oncology; Janssen-Ortho; Myovant Sciences; Pfizer; Research to Practice; UpToDate
Research Funding - Janssen-Ortho (Inst)
Travel, Accommodations, Expenses - Advanced Prostate Cancer Society
 
Xiao X. Wei
Honoraria - OncLive
Consulting or Advisory Role - Novartis; Novartis
Research Funding - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Corvus Pharmaceuticals
 
Bridget Whelpley
No Relationships to Disclose
 
Praful Ravi
Research Funding - Bayer (Inst); Lilly (Inst); Telix Pharmaceuticals (Inst)
 
Heather Jacene
Honoraria - Blue Earth Diagnostics; Munrol
Consulting or Advisory Role - Advanced Accelerator Applications; spectrum dynamics
Research Funding - Blue Earth Diagnostics (Inst); GTx (Inst); Siemens Healthineers (Inst)
Travel, Accommodations, Expenses - GE Healthcare